Probi AB (publ) (PROB.ST)
SEK 348.0
(0.0%)
SEK 348.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 38.21 Million SEK | -28.71% |
| 2022 | 53.6 Million SEK | -14.56% |
| 2021 | 62.73 Million SEK | 105.18% |
| 2020 | 30.57 Million SEK | -34.41% |
| 2019 | 46.61 Million SEK | 0.0% |
| 2018 | - SEK | 0.0% |
| 2017 | - SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| 2014 | - SEK | 0.0% |
| 2013 | - SEK | 0.0% |
| 2012 | - SEK | 0.0% |
| 2011 | - SEK | 0.0% |
| 2010 | - SEK | 0.0% |
| 2009 | - SEK | 0.0% |
| 2008 | - SEK | 0.0% |
| 2007 | - SEK | -100.0% |
| 2006 | 3.45 Million SEK | 0.0% |
| 2005 | - SEK | 0.0% |
| 2004 | - SEK | 0.0% |
| 2003 | - SEK | 0.0% |
| 2002 | - SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - SEK | 0.0% |
| 2024 Q2 | 68.17 Million SEK | 0.0% |
| 2024 Q1 | 36.9 Million SEK | 0.0% |
| 2023 Q3 | 43.48 Million SEK | -8.5% |
| 2023 FY | 38.21 Million SEK | -28.71% |
| 2023 Q2 | 47.52 Million SEK | -4.01% |
| 2023 Q1 | 49.51 Million SEK | -7.63% |
| 2023 Q4 | 38.21 Million SEK | -12.13% |
| 2022 Q3 | 59.99 Million SEK | -1.8% |
| 2022 Q2 | 61.1 Million SEK | 1.1% |
| 2022 FY | 53.6 Million SEK | -14.56% |
| 2022 Q4 | 53.6 Million SEK | -10.66% |
| 2022 Q1 | 60.43 Million SEK | -3.67% |
| 2021 Q3 | 45.66 Million SEK | -1.12% |
| 2021 Q2 | 46.18 Million SEK | 43.44% |
| 2021 Q1 | 32.19 Million SEK | 5.3% |
| 2021 Q4 | 62.73 Million SEK | 37.38% |
| 2021 FY | 62.73 Million SEK | 105.18% |
| 2020 Q3 | 39.86 Million SEK | -2.24% |
| 2020 Q1 | 47.2 Million SEK | 1.27% |
| 2020 FY | 30.57 Million SEK | -34.41% |
| 2020 Q2 | 40.77 Million SEK | -13.61% |
| 2020 Q4 | 30.57 Million SEK | -23.3% |
| 2019 Q4 | 46.61 Million SEK | 0.0% |
| 2019 FY | 46.61 Million SEK | 0.0% |
| 2019 Q3 | - SEK | 0.0% |
| 2019 Q2 | - SEK | 0.0% |
| 2019 Q1 | - SEK | 0.0% |
| 2018 FY | - SEK | 0.0% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2017 Q4 | - SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2017 Q3 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 FY | - SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 Q3 | - SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2015 Q1 | - SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| 2015 Q4 | - SEK | 0.0% |
| 2015 Q3 | - SEK | 0.0% |
| 2015 Q2 | - SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| 2014 Q4 | - SEK | 0.0% |
| 2014 Q2 | - SEK | 0.0% |
| 2014 Q1 | - SEK | 0.0% |
| 2014 Q3 | - SEK | 0.0% |
| 2013 Q3 | - SEK | 0.0% |
| 2013 FY | - SEK | 0.0% |
| 2013 Q4 | - SEK | 0.0% |
| 2013 Q2 | - SEK | 0.0% |
| 2013 Q1 | - SEK | 0.0% |
| 2012 Q1 | - SEK | 0.0% |
| 2012 Q4 | - SEK | 0.0% |
| 2012 Q3 | - SEK | 0.0% |
| 2012 Q2 | - SEK | 0.0% |
| 2012 FY | - SEK | 0.0% |
| 2011 Q3 | - SEK | 0.0% |
| 2011 Q2 | - SEK | 0.0% |
| 2011 Q4 | - SEK | 0.0% |
| 2011 FY | - SEK | 0.0% |
| 2011 Q1 | - SEK | 0.0% |
| 2010 Q4 | - SEK | 0.0% |
| 2010 FY | - SEK | 0.0% |
| 2009 FY | - SEK | 0.0% |
| 2008 FY | - SEK | 0.0% |
| 2007 FY | - SEK | -100.0% |
| 2006 FY | 3.45 Million SEK | 0.0% |
| 2005 FY | - SEK | 0.0% |
| 2004 FY | - SEK | 0.0% |
| 2003 FY | - SEK | 0.0% |
| 2002 FY | - SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AcuCort AB | - SEK | -Infinity% |
| AlzeCure Pharma AB (publ) | - SEK | -Infinity% |
| BioGaia AB (publ) | 26.35 Million SEK | -44.984% |
| Enzymatica AB (publ) | 24.88 Million SEK | -53.561% |
| Enorama Pharma AB (publ) | 303 Thousand SEK | -12511.221% |
| Gabather AB (publ) | - SEK | -Infinity% |
| Klaria Pharma Holding AB (publ.) | - SEK | -Infinity% |
| Moberg Pharma AB (publ) | 3.46 Million SEK | -1002.163% |
| Nanexa AB (publ) | 2.08 Million SEK | -1730.954% |
| Newbury Pharmaceuticals AB (publ) | - SEK | -Infinity% |
| ODI Pharma AB | - SEK | -Infinity% |
| Orexo AB (publ) | 448.4 Million SEK | 91.478% |
| Swedencare AB (publ) | 1.44 Billion SEK | 97.349% |
| Swedish Orphan Biovitrum AB (publ) | 11.35 Billion SEK | 99.664% |
| Toleranzia AB | 850 Thousand SEK | -4395.529% |
| Vivesto AB | 5.18 Million SEK | -637.541% |